USD 0.1
(0.0%)
Breakdown | 2023 | 2022 | 2021 |
---|---|---|---|
Operating Cash Flow | -2.98 Million | -805.17 Thousand | -723.3 Thousand |
Net Income | -16.79 Million | -1.07 Million | -671.81 Thousand |
Depreciation & Amortization | 4855.00 | 3447.00 | 3158.00 |
Deferred income taxes | - | - | - |
Stock-based compensation | 13.56 Million | - | - |
Change in working capital | 235.74 Thousand | 268.19 Thousand | -54.65 Thousand |
Other non-cash items | 256.00 | - | - |
Investing Cash Flow | -5735.00 | -3888.00 | - |
Investments in PPE | -5735.00 | -3888.00 | - |
Acquisitions | - | - | - |
Investment purchases | -65.79 Million | - | - |
Sales/Maturities of investments | - | - | - |
Other Investing Activities | 65.79 Million | - | - |
Financing Cash Flow | 3.38 Million | 873.06 Thousand | 689.78 Thousand |
Debt repayment | -350 Thousand | -350 Thousand | - |
Dividends payments | - | - | - |
Common Stock Repurchased | - | -247.64 Thousand | - |
Common Stock Issuance | 68.16 Million | 873.06 Thousand | 689.78 Thousand |
Other Financing Activities | -64.42 Million | 1.57 Million | 689.78 Thousand |
Accounts receivables | -333.59 Thousand | - | - |
Accounts payables | - | - | - |
Inventory | - | 163.25 Thousand | -163.25 Thousand |
Other working capital | 235.74 Thousand | 104.94 Thousand | 108.6 Thousand |
Cash at beginning of period | 81.62 Thousand | 31.69 Thousand | 59.03 Thousand |
Cash at end of period | 17.78 Thousand | 81.62 Thousand | 31.69 Thousand |
Capital Expenditure | -5735.00 | -3888.00 | - |
Effect of forex changes on cash | -463.91 Thousand | -14.06 Thousand | 6184.00 |
Net cash flow / Change in cash | -63.83 Thousand | 49.93 Thousand | -27.34 Thousand |
Free Cash Flow | -2.98 Million | -809.06 Thousand | -723.3 Thousand |
Breakdown | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 | 2022 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -4128.70 | -2491.50 | 93.08 Thousand | -16.79 Million | 230.52 Thousand | 151.34 Thousand |
Depreciation & Amortization | 1.35 | - | 1.32 | 4855.00 | 1.32 | 1.11 |
Deferred income taxes | - | - | -10.75 Thousand | - | 1429.00 | - |
Stock-based compensation | - | - | 6784.07 | 13.56 Million | 6784.07 | - |
Change in working capital | 2805.56 | - | 367.29 Thousand | 235.74 Thousand | 302.77 Thousand | 154.06 Thousand |
Other non-cash items | 2491.50 | 2491.50 | -712.17 Thousand | 256.00 | -713.24 Thousand | -567.63 Thousand |
Investing Cash Flow | 608.87 | - | 16 Million | -5735.00 | -722.29 | -2.87 |
Investments in PPE | - | - | - | -5735.00 | - | -2.87 |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -250 Thousand | -65.79 Million | - | - |
Sales/Maturities of investments | - | - | 16.25 Million | - | - | - |
Other Investing Activities | 608.87 | - | - | 65.79 Million | - | - |
Financing Cash Flow | 754.66 | - | -15.72 Million | 3.38 Million | 945.96 | 748.33 |
Debt repayment | - | - | -357.59 Thousand | -350 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -16.08 Million | - | - | - |
Common Stock Issuance | - | - | - | 68.16 Million | - | - |
Other Financing Activities | 754.66 | - | 945.96 | -64.42 Million | 945.96 | 748.33 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2805.56 | - | 367.29 Thousand | 235.74 Thousand | 302.77 Thousand | 154.06 Thousand |
Cash at beginning of period | - | - | 99.79 Thousand | 81.62 Thousand | 278.29 Thousand | 540.52 Thousand |
Cash at end of period | 3.80 | - | 113.23 Thousand | 17.78 Thousand | 99.79 Thousand | 278.29 Thousand |
Capital Expenditure | - | - | - | -5735.00 | - | -2.87 |
Effect of forex changes on cash | -37.94 | - | -223.67 | -463.91 Thousand | -223.67 | -8.28 |
Net cash flow / Change in cash | 3.80 | - | 13.44 Thousand | -63.83 Thousand | -178.5 Thousand | -262.23 Thousand |
Free Cash Flow | -1321.79 | - | -262.54 Thousand | -2.98 Million | -178.5 Thousand | -262.23 Thousand |
RELINFRA
CY4
8293
SER
ZENSARTECH
INKP